Medical Weight Loss for Whitney, Nevada Residents

Whitney, Nevada residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Whitney through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Honest pricing for Whitney patients: compounded semaglutide starts at $166 per month ($499 for the 90-day program) and tirzepatide from $233 per month, billed separately. No distance surcharge for Nevada residents. Doctor review just $119 (medication separate).

Why Whitney Residents Choose New Hope Weight Loss

Some patients in Whitney are weighing semaglutide against tirzepatide, and that is a conversation worth having with a doctor, not a website. Dr. Anjmun Sharma helps you understand the trade-offs, the cost difference between $166 and $233 a month, and what the trial data actually showed, with semaglutide averaging about 15 to 17 percent body-weight loss and tirzepatide reaching up to 22.5 percent at qualifying doses. These are compounded, not brand-identical, and results vary, so the choice should be informed.

Whitney is served by telemedicine from our Costa Mesa, California clinic. The same physician-supervised semaglutide and tirzepatide programs are available by secure video, with medication shipped to your door.

For anyone in Whitney, Nevada, the distance to Costa Mesa simply does not matter, because Dr. Anjmun Sharma manages your entire program by video and message rather than in person. We care for patients throughout Whitney and the southeastern Las Vegas Valley. We bill the $119 physician visit clearly and keep your medication billed separately, so the cost is transparent before anything ships to Nevada.

You can start this week from anywhere in Nevada, because telehealth removes the drive, the parking, and the weeks of waiting that a local clinic would require. We accept HSA and FSA cards for the $119 physician review, which lets many Whitney patients use pre-tax dollars toward their care. Nevada is one of the fastest-growing states in the West, and New Hope Weight Loss cares for patients across it entirely by telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Semaglutide 90-Day Metabolic Reset

This is the program most people ask us about first. For $499 across 90 days, or from $166/mo, you get semaglutide plus monthly physician oversight. Semaglutide uses the same active ingredient as Wegovy and Ozempic, and branded-drug trials averaged 15 to 17 percent body-weight loss. It is compounded, so it is not FDA-approved or brand-identical, and results vary.

Tirzepatide for a dual-pathway approach

From $233/mo, tirzepatide combines GLP-1 and GIP signaling. Branded-drug studies showed up to 22.5 percent loss at qualifying doses, a high-end figure that is not typical. It shares an active ingredient with Mounjaro and Zepbound.

Plan on a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted, and there is no extra charge for Whitney telehealth visits.

How Telehealth Works for Whitney

Here is how the whole thing works, start to finish, for anyone in Whitney.

First, you fill out an intake and quiz about your weight history and current health. Next, Dr. Sharma looks it over and meets you by secure video, almost always within 48 hours, to see whether compounded semaglutide or tirzepatide fits your situation. Then, if she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Whitney address in cold-pack packaging built to protect it on the road. After that, every follow-up is a video visit, so the care continues no matter where you are in .

Frequently Asked Questions, Whitney

Can people from Whitney get treated by New Hope Weight Loss?

Absolutely. We operate one physical clinic in Costa Mesa, California, and we provide telehealth care to Whitney, Nevada. Whether you are in Whitney and the southeastern Las Vegas Valley or elsewhere in the area, the path is the same. Dr. Anjmun Sharma meets you by video and confirms if a compounded GLP-1 program is right for you.

Do Whitney patients ever have to come into the office?

Never. Care is delivered entirely through telehealth, which means Whitney residents stay home for consults, follow-ups, and questions. Once Dr. Sharma approves you, your compounded semaglutide or tirzepatide is mailed to Whitney inside cold-pack packaging that holds the right temperature in transit.

What is the cost breakdown for Whitney?

You pay $119 for the physician review. Semaglutide begins at $166 a month, or $499 across 90 days, and tirzepatide begins at $233 a month. Medication is a separate charge. We accept HSA, FSA, Klarna, and Affirm payments, and there is no distance surcharge applied to anyone in Whitney.

What areas of Whitney do you serve?

We serve patients from across Whitney by telehealth, including Whitney and the southeastern Las Vegas Valley.

Is bilingual (Spanish) telehealth care available for Whitney patients?

Yes. Anamaria Schmidt, our bilingual clinical coordinator, handles calls, WhatsApp, and Spanish-language consultations, with Dr. Sharma supervising every case. The full telehealth program, intake, consultation, and follow-up, is available in Spanish for Whitney patients.

Whitney Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Whitney, Nevada by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.